7-152162854-T-C
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_170606.3(KMT2C):c.10723A>G(p.Thr3575Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000508 in 1,614,076 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T3575S) has been classified as Likely benign.
Frequency
Consequence
NM_170606.3 missense
Scores
Clinical Significance
Conservation
Publications
- Kleefstra syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_170606.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KMT2C | NM_170606.3 | MANE Select | c.10723A>G | p.Thr3575Ala | missense | Exon 43 of 59 | NP_733751.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KMT2C | ENST00000262189.11 | TSL:1 MANE Select | c.10723A>G | p.Thr3575Ala | missense | Exon 43 of 59 | ENSP00000262189.6 | ||
| KMT2C | ENST00000360104.8 | TSL:1 | c.6343A>G | p.Thr2115Ala | missense | Exon 15 of 31 | ENSP00000353218.4 | ||
| KMT2C | ENST00000473186.5 | TSL:1 | n.8434A>G | non_coding_transcript_exon | Exon 29 of 46 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000271 AC: 68AN: 251326 AF XY: 0.000280 show subpopulations
GnomAD4 exome AF: 0.000528 AC: 772AN: 1461886Hom.: 1 Cov.: 33 AF XY: 0.000488 AC XY: 355AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000315 AC: 48AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74360 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
KMT2C-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
not provided Benign:1
not specified Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at